Literature DB >> 7561926

Chronic hypertrophic cranial pachymeningitis associated with HTLV-I infection.

Y Kawano1, J Kira.   

Abstract

Two patients presenting with recurrent multiple cranial neuropathy showed diffuse thickening and gadolinium enhancement of the dura mater on brain MRI. Both had anti-HTLV-I antibodies in serum. A quantitative polymerase chain reaction study of the peripheral blood disclosed that the HTLV-I proviral DNA loads increased considerably in one case and moderately in the other. Both showed a spontaneous proliferation of peripheral blood lymphocytes as well as an increase in helper/inducer T cells. Neither had any other underlying infections or autoimmune diseases. Thus it is possible that hypertrophic pachymeningitis developed as a result of multiorgan involvement of HTLV-I infection in these patients.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7561926      PMCID： PMC486083          DOI： 10.1136/jnnp.59.4.435

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  10 in total

1.  Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.

Authors:  J Kira; Y Koyanagi; T Yamada; Y Itoyama; I Goto; N Yamamoto; H Sasaki; Y Sakaki
Journal:  Ann Neurol       Date:  1991-02       Impact factor: 10.422

2.  Chronic inflammatory arthropathy associated with HTLV-I.

Authors:  K Nishioka; I Maruyama; K Sato; I Kitajima; Y Nakajima; M Osame
Journal:  Lancet       Date:  1989-02-25       Impact factor: 79.321

3.  T-lymphocyte alveolitis in HTLV-I-associated myelopathy.

Authors:  M Sugimoto; H Nakashima; S Watanabe; E Uyama; F Tanaka; M Ando; S Araki; S Kawasaki
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

4.  Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.

Authors:  M Pfisterer; F Burkart; G Jockers; B Meyer; S Regenass; D Burckhardt; H E Schmitt; J Müller-Brand; K Skarvan; P Stulz
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

5.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

6.  Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP).

Authors:  Y Iwasaki
Journal:  J Neurol Sci       Date:  1990-04       Impact factor: 3.181

7.  TNF-beta produced by human T lymphotropic virus type I-infected cells influences the proliferation of human endothelial cells and fibroblasts.

Authors:  F Yu; Y Itoyama; J Kira; K Fujihara; T Kobayashi; T Kitamoto; A Suzumura; N Yamamoto; Y Nakajima; I Goto
Journal:  J Immunol       Date:  1994-06-15       Impact factor: 5.422

8.  Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy.

Authors:  Y Itoyama; S Minato; J Kira; I Goto; H Sato; K Okochi; N Yamamoto
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

9.  Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy.

Authors:  Y Itoyama; J Kira; N Fujii; I Goto; N Yamamoto
Journal:  Ann Neurol       Date:  1989-08       Impact factor: 10.422

10.  HTLV-I uveitis: a distinct clinical entity caused by HTLV-I.

Authors:  M Mochizuki; T Watanabe; K Yamaguchi; K Takatsuki; K Yoshimura; M Shirao; S Nakashima; S Mori; S Araki; N Miyata
Journal:  Jpn J Cancer Res       Date:  1992-03
  10 in total
  5 in total

1.  Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.

Authors:  Martina Absinta; Irene C M Cortese; Luisa Vuolo; Govind Nair; Manori P de Alwis; Joan Ohayon; Alessandro Meani; Vittorio Martinelli; Roberta Scotti; Andrea Falini; Bryan R Smith; Avindra Nath; Steven Jacobson; Massimo Filippi; Daniel S Reich
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

2.  Wave-like appearance of diffuse pachymeningeal enhancement associated with intracranial hypotension.

Authors:  M Tosaka; N Sato; H Fujimaki; A Takahashi; N Saito
Journal:  Neuroradiology       Date:  2005-05-11       Impact factor: 2.804

3.  Idiopathic hypertrophic spinal pachymeningitis with an osteolytic lesion.

Authors:  Tae Keun Jee; Sun-Ho Lee; Eun-Sang Kim; Whan Eoh
Journal:  J Korean Neurosurg Soc       Date:  2014-08-31

4.  Hypertrophic spinal pachymeningitis associated with human T-cell lymphotrophic virus-1 infection and Sjogren's syndrome: A case report and brief literature review.

Authors:  Costansia A Bureta; Masahiko Abematsu; Hiroyuki Tominaga; Yoshinobu Saitoh; Ichiro Kawamura; Satoshi Nagano; Takao Setoguchi; Yasuhiro Ishidou; Takuya Yamamoto; Setsuro Komiya
Journal:  Int J Surg Case Rep       Date:  2018-03-15

Review 5.  ANCA-Associated Systemic Vasculitis Presenting With Hypertrophic Spinal Pachymeningitis: A Report of 2 Cases and Review of Literature.

Authors:  Xia Li; Jiuliang Zhao; Qian Wang; Yunyun Fei; Yan Zhao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.